in its $3.57 billion acquisition of Syntel, Inc.

• and Brookfield Property Partners L.P. (BPY) in BPY's $14.4 billion acquisition of the approximately 66% of common stock that it did not already own of GGP Inc. (f/k/a General Growth Properties Inc.).
• in its pending approximately $4.8 billion acquisition of a 62% stake in Oaktree Capital Group, LLC.
• in its $2.8 billion acquisition of all of the outstanding common shares not already owned by Brookfield Property Partners L.P. of Rouse Properties, Inc., a REIT that owns and manages regional shopping malls in the United States.

• The Dow Chemical Company in its $130 billion all-stock merger of equals with E. I. du Pont de Nemours and Company.
• Dow in its approximately $40 billion spin-off from DowDuPont Inc. as part of DowDuPont's separation into three independent, publicly traded companies, one each for its agriculture, materials science and specialty products businesses.

• in its approximately $8 billion acquisition of Loxo Oncology, Inc.
• in its $5.4 billion acquisition of the animal health business of Novartis AG, making Lilly's animal health business the second-largest animal health company by global revenue.
• in its acquisitions of CoLucid Pharmaceuticals, Inc., Avid Radiopharmaceuticals, Inc., Lohmann SE, ChemGen Corp., the world-wide rights to an intranasal glucagon from Locemia, and the North American rights to Erbitux® (cetuximab) (including commercialization and manufacturing responsibilities) from Bristol-Myers Squibb Company; and in the sale of veterinary assets to Virbac SA.

• in its $3.4 billion sale of GE Water to SUEZ.
• in its $2.6 billion sale of GE Industrial Solutions.

in its strategic plan to sell most of GE Capital’s assets and GE Capital:

• in its $32 billion sale of its global Commercial Distribution Finance, North American Vendor Finance and North American Corporate Finance platforms to Wells Fargo & Co.
• in its $6.9 billion sale of its United States, Mexico, Australia and New Zealand fleet businesses to Element Financial Corporation, and in the sale of its European fleet businesses to Arval Service Lease S.A.
• in the sale of General Electric Railcar Services LLC to Wells Fargo & Co., and sale of its North American tank car rail assets and railcar repair business to Marmon Holdings, Inc.
• in its sale of a 23.3% stake in Hyundai Capital Services, a joint venture between Hyundai Motor Company and GE Capital and a provider of consumer financial products, to Hyundai Motor Company and Kia Motors Corporation.

• in its $76 billion acquisition of all of the outstanding equity securities of Kinder Morgan Energy Partners, L.P., Kinder Morgan Management, LLC, and El Paso Pipeline Partners, L.P. — at the time, the largest energy merger since Exxon and Mobil combined in 1999.
• in its $5 billion acquisition of Copano Energy.
• in its $38 billion acquisition of El Paso Corporation, creating one of the largest energy companies in the world and in El Paso’s concurrent $7.15 billion sale of its E&P production business, EP Energy Corporation.
• and Kinder Morgan Canada Limited in their $3.5 billion sale of Trans Mountain Pipelines Inc. and the Trans Mountain Expansion Project to the Government of Canada.

• in the $2.15 billion sale of its convenience store business unit to EG Group.
• in its acquisition of Vitacost.com, Inc.
• in its acquisition via tender offer of Roundy’s, Inc.
• in its strategic partnership with, and investment in, Lucky’s Market.

• in its $1.3 billion acquisition of the CeraVe, AcneFree and AMBI skincare product brands from Valeant Pharmaceuticals International, Inc. (n/k/a Bausch Health Companies).
• in its $1.2 billion acquisition of IT Cosmetics, LLC from its founders, Jamie Kern Lima and Paulo Lima, and TSG Consumer Partners.

• in its formation MGM Growth Properties LLC (MGP), a controlled REIT, and in corporate, real estate and tax aspects of MGP’s $1.05 billion initial public offering.
• in its $1.175 billion sale of the real property of the Borgata Hotel Casino & Spa in Atlantic City, New Jersey to MGM Growth Properties LLC. The sale followed MGM Resorts’ $900 million acquisition of the 50% interest in the Borgata that it did not already own from Boyd Gaming Corporation.

• in its $25 billion exchange of Merial, its animal health business, for the consumer healthcare business of Boehringer Ingelheim GmbH.
• in its $11.6 billion acquisition of Bioverativ Inc.
• in its $4.8 billion acquisition of Ablynx NV.
• in its $2.35 billion sale of Zentiva to Advent International.
• in its up to $750 million acquisition of Protein Sciences Corporation.
• in its sale of Laboratoire Oenobiol S.A.S. to Vemedia Manufacturing B.V.

in its $14.6 billion merger with Discovery Communications, Inc.

• in its $4.4 billion acquisition of AOL Inc. Frederick Green was named “Dealmaker of the Week” by The Am Law Daily (May 2015) for his lead role advising on this transaction.
• in its acquisitions of Sensity Systems Inc., Intel Media, EdgeCast Networks, Inc. and Terremark Worldwide Inc., and in Terremark’s subsequent acquisition of CloudSwitch.

• Willis Group Holdings plc in its $18 billion merger of equals with Towers Watson & Co.
• Willis Towers Watson PLC in its pending up to $1.4 billion acquisition of TRANZACT.